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In silico assessment of the dosimetric
quality of a novel, automated radiation
treatment planning strategy for linac-based
radiosurgery of multiple brain metastases
and a comparison with robotic methods
Krzysztof Slosarek1†, Barbara Bekman1, Jacek Wendykier1, Aleksandra Grządziel1,2, Antonella Fogliata3
and Luca Cozzi3,4*†
Abstract
Background: To appraise the dosimetric features and the quality of the treatment plan for radiosurgery of multiple
brain metastases optimized with a novel automated engine and to compare with plans optimized for robotic-based
delivery.
Methods: A set of 15 patients with multiple brain metastases was selected for this in silico study. The technique under
investigation is the recently introduced HyperArc. For all patients, three treatment plans were computed and compared:
i: a HyperArc; ii: a standard VMAT; iii) a CyberKnife. Dosimetric features were computed for the clinical target volumes as
well as for the healthy brain tissue and the organs at risk.
Results: The data showed that the best dose homogeneity was achieved with the VMAT technique. HyperArc allowed
to minimize the volume of brain receiving 4Gy (as well as for the mean dose and the volume receiving 12Gy, although
not statistically significant). The smallest dose on 1 cm3 volume for all organs at risk is for CK techniques, and the biggest
for VMAT (p < 0.05). The Radiation Planning Index coefficient indicates that, there are no significant differences among
the techniques investigated, suggesting an equivalence among these.
Conclusion: At treatment planning level, the study demonstrates that the use of HyperArc technique can significantly
improve the sparing of the healthy brain while maintaining a full coverage of the target volumes.
Keywords: HyperArc, CyberKnife, VMAT, Multiple brain metastases, Radiosurgery
Background
The high incidence of (multiple) brain metastases is a
heavy burden to any clinical radiation oncology depart-
ment and requires the development of appropriate and
tailored strategies for their treatment. If whole brain ir-
radiation is consolidated and generally accepted as well as
the use of stereotactic radiosurgery (SRS) for solitary or
few (up to three) lesions are consolidated practice, the use
of SRS to treat multiple lesions took longer to reach a suf-
ficient level of evidence. Nevertheless, its considered quite
acceptable in the modern management of patients with
brain metastases [1–5] although care should be given to
the selection of the techniques and of the patients.
Due to the anatomical complexity of the brain, several
trade-offs between target coverage and OAR sparing
might arise. The use of a coplanar approach to the arc
geometry leaves space for improvement. Some groups
explored the possibility to deliver modulated treatments
(with fixed beams or arcs) with conventional c-arm lin-
ear accelerators using most of the 4π space, i.e. making
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extensive use of non-coplanar beam arrangements and
creating complex delivery trajectories for the couch-
gantry-collimator system around the patient [6–12].
These investigators focused on stereotactic irradiation in
the brain, lungs and prostate and have shown that sig-
nificantly sharper dose gradients can be achieved with
this approach. The original investigations published pro-
vided evidence of benefit and proof of principle for
smaller tumors.
The aim of this study was to explore a practical imple-
mentation of a kind-of 4π technique in a clinically re-
leased treatment planning system, the HyperArc (HA).
A new dedicated optimization engine and an automated
planning procedure was recently released for clinical
use. This approach is based on the seminar work of the
group of the University of Alabama [13, 14] and com-
bines the use of multiple non-coplanar Volumetric Mod-
ulated Arc Therapy (VMAT) with a single isocenter to
some dedicated optimization strategies. We aimed to ap-
praise and report about the quality of the treatment
plans achieved with this technique (mono-isocentric by
definition) and to compare this with respect to plans op-
timized for a robotic delivery with Cyberkinfe (CK),
“multi-isocentric” by definition. In fact, if some extensive
literature exists in the discussion of CK, even in com-
parison with VMAT (in its RapidArc (RA) form) [15–
23], this might result among the first reports comparing
HA and CK for multiple brain metastases. Non-coplanar
RA for multiple brain metastases, was appraised also by
Liu [24] in comparison with Gamma Knife based plans
demonstrating an improved level of conformity and a re-
duced involvement of healthy brain. As an extra com-
parison and a kind of internal benchmark, we added in
the study also plans optimized with conventional VMAT
approach, obtained without the special planning tools
available for the HA plans.
Methods
Patients and treatment plans
A group of 15 patients, previously treated for multiple
brain metastases, were selected for this retrospective, in
silico study. The number of lesions ranged from 3 to 8 (3
lesions: 11 patients, 5,6 or 8 lesions: one patient each) For
each case, the treatment plans were optimized and com-
puted with the dose prescription chosen for the clinical
treatment which ranged from 10.0 to 24.0 Gy depending
on the lesion location and the presence of nearby dose-
limiting organs at risk. The clinical delivery (with CK) oc-
curred in 1 fraction for 7 patients, in 2 fractions for 6 pa-
tients and in 3 fractions for 2 patients. For the planning
study, a single fraction was considered in all cases. As
usual in a planning comparison study, to avoid any bias
derived from different normalization or prescription
methods among techniques, the same strategy was applied
to all cases for all techniques. The planning strategy re-
quired full coverage with a dose normalization set so that:
V100% = 95% for the target volumes (defined as the total
gross target volume GTV) and the minimization of the
dose to all involved structures (including the remaining
healthy brain and, according to the case, the eyeballs, the
lenses, the optic nerves, the chiasm, the brainstem) ac-
cording to the ALARA principle. For all patients 3 sets of
plans were designed, optimized and computed, according
to the following:
HyperArc: this is the technique under investigation. It
was recently released for clinical use and its planning
workflow consists of three phases:
i) Definition of the basic plan features: list of lesions
and individual dose prescription (without limits in
the number of possible targets, all with a possibly
individual dose prescription);
ii) Selection of the arc geometry from a class solution
of 5 non-coplanar arcs arranged with one single
isocenter, automatically located according to the
mutual distance between each lesion. Users can only
select or de-select some arcs but cannot modify their
trajectories (length and couch rotation).
iii)Automatic optimization of the collimator angle. This
tool aims to orient the MLC leaves motion as much
as possible along directions orthogonal to the ideal
line connecting two or more lesions. This should
result in the maximization of the dosimetric
separation of the lesions and the reduction of the
so-called dose bridging effect.
iv) The process can directly continue into the
optimization and final dose calculation phases.
Figure 1 shows a screen shot of the graphic interface
used to generate the treatment plan arrangements. The
arcs (up to five) are all connected into one automated se-
quence for the delivery, meaning that the entire treatment
can be performed with one single virtual “beam-on” phase.
During couch rotations no beam is active and the image
guidance procedure requires that a full CBCT is acquired
prior to the first arc with couch set at 0 degrees and planar
2D images can be further acquired prior of each arc. Op-
tionally users can run an in silico dry run of the delivery
to verify the absence of any risk of collision. Any change
in the geometrical arrangements introduced by users,
would void the HA nature of the plan and disable automa-
tion of delivery (as well as preventing optimization).
Plans were optimized in Eclipse (v.15.5) for the Edge de-
livery system equipped with a multileaf collimator with
2.5 mm resolution in the central region ((Varian Medical
Systems, Palo Alto, USA). The Acuros dose calculation al-
gorithm was used for the final calculation while the dedi-
cated SRS version of the Photon Optimizer engine was
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applied for the inverse planning with a dose grid reso-
lution of 1 mm. In the optimization two SRS specific tools
were applied. Firstly the stereotactic normal tissue object-
ive. This mimic what described in [13, 14] and automatic-
ally generates virtual shells around the targets to control
and minimize the dose bridging effect between lesions and
maximizes the steepness of the dose gradient. Secondly
the automatic low dose objective (ALDO) option was se-
lected to automate the management of the optimization
priorities to the targets in order to achieve the same de-
gree of coverage (ideally full coverage) to all lesions. The
use of ALDO prevents the possibility to set upper con-
straints to the target volumes, differently from what do-
able with standard planning.
VMAT: Each VMAT plan, optimized in Eclipse with the
RapidArc technique with the same treatment planning
system as above (using the version 13.6), was optimized
with a variable number of partial or full coplanar or non-
coplanar arcs (from 2 to 5). A single isocenter strategy (to
mimic as much as possible the HA approach) was applied
to most of patients (8 out of 15). The remaining cases
were planned with multiple isocentres in order to achieve
plans which were at least considered clinically acceptable
and not affected by severe sub-optimal dosimetric charac-
teristics. The exact choice of the beam geometry was due
by the number and location of the lesions with the general
aim to minimize the involvement of the healthy structures
in the brain. 6MV flattening filter free photon beams were
chosen (with a maximum dose rate of 1400 MU/min)
from a TrueBeam STX delivery platform (equipped with a
MLC of 2.5 mm spatial resolution). For the final dose cal-
culation, the same algorithm and resolution were applied
as for the HA plans. To note that, for more than one le-
sions, the choice of the proper angle of collimation is not
trivial. If tumors are placed in such way, that for any gan-
try angle there is no overlapping in the beam projection,
the MLC directions should be set far less perpendicular to
the arc plane. But for more sophisticated spatial placing
the special set-up is required. As an example, Fig. 2 illus-
trates the case of a 5-tumors case and its problems of tar-
gets overlapping on BEV projection is shown below.
There are two subsets of tumors: red ones and cyan ones,
the red line is the projection of arc plane. The probe of
MLC fitting for full arc to the all tumors failed. Left panel
shows irradiation of large volume of health tissue placed
between cyan tumors for a particular gantry angle. Any
other collimator angle would cause similar problems.
In that case the better solution was to use two arcs, for
cyan and red tumors independently (right panel, shown
only MLC shape for cyan subset of targets). It seems that
the best situation is when (1) the selected group of tumors
rotates in one plane (some kind of tumors overlapping for
projection occurs), (2) arc plane is perpendicular to the
direction of leaf movements and (3) tumors are not con-
cave in the linking direction for any projection. Sometimes
a slight couch angle (less than 10 degrees) could give some
improvement.
Cyberknife: Each CK plan was optimized with the Multi-
plan v.4.6 (Accuray Inc, USA) treatment planning system
using the RayTracing algorithm, a dose calculation grid of
Fig. 1 A screen shot of the user’s interface for the definition of the HyperArc treatment plan
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0.98 mm (the resolution of the CT dataset) was applied
for the final calculations. The mean number of nodes per
plan was 110 (ranging from 65 to 259) with 217 beam di-
rections (152–351). For the collimation of the beams, both
fixed size tubes or the Iris collimator were selected due to
the different size, number and location of the lesions. The
actual selection was performed according to the prefer-
ence of the planners. For all plans, the dose cubes were
exported in DICOM format and imported in the Eclipse
system for planning comparison purposes.
Quantitative and statistical analysis
Qualitative and quantitative analysis was performed on
the dose distributions and the cumulative dose volume
histograms (DVH) by computing a number of dose-
volume metrics for the target volume and the organs at
risk. For the targets, the analysis was carried out on the
sum of all the targets, the near-to-minimum dose was
defined as D98% and the homogeneity as: (D2%-D98%)/
Dprescription. For the organs at risk the mean or the near-
to-maximum doses were accounted for. The Paddick
conformity and gradient indexes were computed accord-
ing to the original formulation [25, 26] for the total tar-
get volumes.
In addition to these parameters and in agreement with
the methods described in [27], the Radiation Planning
Index (RPI) was computed. This is defined as:
Where: k is the number of PTV (or GTV) structures,
n is the number of critical structures,
RDi max
0 V
OaRidD is
the area under the graph for the integral DVH for a
given OaRi, Dimax is the maximum dose for the i-th
structure of OAR among all compared plans, expressed
in [Gy], Wi is the weight factor assigned to i-th structure
OaR,
RD j max
0 V
PTV jdD is the area under the graph for the
integral DVH for the PTVj, Djmax is maximum dose for
the j-th structure of PTV (or GTV) among all compared
plans, expressed in [Gy], SDevj is the standard deviation
expressed as a percentage for the structure of PTVj in
the analyzed plan, Wj is the weight factor assigned to j-
th - PTV. The weight describes the importance of the
given structure. If OARs sparing is more important than
PTV coverage then Wi >Wj (0 ≤W ≤ 1).
When the critical structures receive 0% of the reference
dose and the whole tumour volume is covered by 100% of
the prescribed isodose and the dose distribution inside the
target is homogeneous (SDev = 0) then RPI = 1. RPI = 0
when each OAR volume is covered with the homogeneous
maximal dose or standard deviation SDev is equal to 1. In
clinical practice RPI values are in the range of 0 to 1.
For each investigated parameter, significance of the
differences observed among the techniques was com-
puted with nonparametric Kruskal-Wallis tests and the
threshold was set to 0.05.
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Fig. 2 Conceptual visualization of the complexity of the manual arrangement of the collimator angle for the standard VMAT planning. On the contrary,
the new HyperArc engine, includes an automatic optimization of the collimator angle
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Results
Figure 3 presents the isodose distribution for a represen-
tative case (with 3 lesions) in three axial planes across
the extension of the metastases for the three techniques
under investigation. The dose prescription for this case
was 15Gy and the color wash ranges from 13.5 (90% of
the prescription) to 17.0 Gy - first row; from 10.0 Gy to
17.0 Gy – second row and from 4.0 Gy to 17.0 Gy in
third row. Columns from left to right are HA, VMAT
and CK respectively. From a qualitative perspective, the
illustration demonstrates the differences in terms of gra-
dients and of dose bridging mitigation among the vari-
ous solutions. Figure 4 presents the cumulative DVH for
the cumulative target volume and for the healthy brain
for the same case. The data illustrates the reduction of
the medium to high doses achieved by HA with respect
to both techniques. Concerning the target, a compatible
coverage was obtained while CK and HA presented an
(equivalent) higher maximum dose which could be
avoided in the VMAT case.
Concerning the targets, Fig. 5a illustrates the boxplot
relative to the near-to-minimum dose (in %) for all the
techniques. The error bars correspond to 1 standard de-
viation, the solid box to the mean ± 1 standard error. No
difference was found in this case (p = 0.28). Figure 5b
provides the results for the homogeneity of the dose dis-
tributions. In this case a significant difference was ob-
served between CK and HA (p = 0.02) and between
VMAT and HA (p = 0.01). The Paddick conformity index
resulted comparable for all techniques without statisti-
cally significant differences (it resulted 0.87 ± 0.07, 0.81
± 0.09 and 0.86 ± 0.06 for CK, VMAT and HA respect-
ively). No difference was observed among the techniques
for the target volume receiving 90% of the planning dose
while for the volume receiving 110% there was a signifi-
cant difference (p = 0.03) between CK and HA or
VMAT. The Paddick gradient index resulted comparable
between CK and HA with no statistically significant dif-
ference although it was slightly better for HA while it
was significantly worse for VMAT with respect to both
the alternatives (5.5 ± 1.5, 6.3 ± 1.6 and 5.0 ± 1.4 respect-
ively for CK, VMAT and HA).
Figure 6 summarizes the analysis on the organs at risk.
No significant differences were observed for the brain-
stem, the chiasm and the optic nerves. Concerning the
lenses, the difference between VMAT and HA was statis-
tically significant (p = 0.02) while it resulted at the edge
of significance between CK and HA (p = 0.05). Concern-
ing the eyes although the mean findings suggest better
results for CK, no significant difference was observed
between CK and HA while this was the case when com-
paring CK vs. VMAT resulted in a p = 0.02.
Figure 7 illustrates the data for the healthy brain. In
the first panel the mean dose is reported while in the
second and in the third panel the V12Gy and the V4Gy
data. As noticed, no difference was observed for the
mean dose (p = 0.2) among the techniques. Only for
V4Gy differences are statistically significant (p = 0.01) for
the median dose, the smallest median dose is for HA
technique.
Figure 8 summarizes the analysis carried on by means
of the RPI. In the first panel when all the structures per
each plan are included and in the second panel when
only the targets and the healthy brain are considered. In
the first instance a near-to-significance difference was
observed (p = 0.05) among the techniques while this was
not the case in the second case (p = 0.62). To be noticed
that a RPI value proximal to 1 means that the dose dis-
tributions meet ideally the planning objectives, while a
RPI = 0 corresponds to the worst case. When all struc-
tures are included in the RPI calculation, CK resulted
better (although at the edge of significance) while a sub-
stantial equicalence was observed when only the healthy
brain was included as a relevant organ at risk.
The evaluation of the overall delivery time for the
VMAT plans resulted in a range of 2.2 to 11.2 min
(average: 5.9 ± 3.1 mins). In this case imaging and posi-
tioning time was not included since it might depend
upon the protocols and the image guidance strategies.
Since a single cone-beam CT acquisition requires
about 3 min (acquisition and post-processing), its real-
istic to consider that an imaging plus verification time
Fig. 3 Axial views of the dose distribution for an example case with
three lesions for the three different techniques, arranged in columns:
HyperArc, VMAT, CyberKnife. The colorwash is set to 13.5 Gy (90% of
the prescription) to 17.0 Gy – upper row, 10.0 Gy to 17.0 Gy – middle row,
4.0 Gy to 17.0 Gy – lower row. It is qualitatively noticeable the different
management of the dose bridging and of the gradients between the
different approaches
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of 10–15 min might be added to the process.. Due to
the automation of the delivery process and the integra-
tion of the imaging time, the total computed time re-
quired to complete a HA fraction resulted quite
shorter than the corresponding time for VMAT. In
fact, if the delivery time due to beam on is equivalent
among the two approaches, the reduction of the dead
times between arcs and the fast imaging process would
enable the entire image guidance process to be com-
pleted in 5–10 min.
The total delivery time for CK plans resulted in a
range from 37 to 76 min (with an average of 52.0 ± 10.4
mins). This calculated time is relative to a single fraction
inclusive of kV imaging for positioning purposes. One
CK plan was composed of six different plans and was
not accounted above. For this summed plan the total
time of all treatment sessions was 275 mins, assumed
daily treatment of all the tumors.
Discussion
A planning study aiming to compare three different
techniques for the radiosurgical treatment of multiple
brain metastases was carried out. CK, VMAT and the
newly clinically introduced HA (an evolution of the
VMAT from the planning and delivery point of view)
were compared on a cohort of 15 patients. No experi-
mental verification of the dose distributions was per-
formed and included in the study since beyond the
purpose to the project. Nevertheless, both CK and
VMAT are consolidated techniques (and in this perspec-
tive HA falls in the category of the VMAT delivery) and
this point has been already proven by the clinical prac-
tice. However, it is important to keep in mind the differ-
ent therapeutic dose definition in VMAT and CK
technique [28].
Concerning the field of the in-silico comparison, the
dose distributions optimized for the three techniques
Fig. 4 The cumulative dose volume histograms of the example case with three lesions for the three techniques under investigation. In red the total target
volume, in green the healthy brain
a b
Fig. 5 Summary of the analysis of the PTV data. a near-to-minimum dose; b homogeneity. The central point represents the mean, the solid box the standard
error and the bars the standard deviation
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under investigation, namely CK, VMAT and HA tech-
niques resulted comparable from a clinical perspective.
The main remarkable difference was observed for the esti-
mated treatment time, significantly higher for CK com-
pared to the VMAT based approaches. The delivery time
for HA is further reduced compared to the VMAT. The
mean exposition time (when beam is on) is for CK - about
35 mins, for VMAT - 3 mins and 4 mins for HA
technique.
Concerning the analysis of the dose distributions, the
best homogeneity was observed for the VMAT and the
worst with HA with CK falling nearer to VMAT; the ob-
served differences were statistically significant. Regarding
the organs at risk, the main discrepancies among tech-
niques were observed for the lensed and the eyes while no
remarkable dependency was observed for the brainstem,
the chiams and the optic nerves. In the case of the lenses
and the eyes, the average findings demonstrate better
sparing for CK. The absence or limed value of the statis-
tical significance of the observed discrepancy might de-
pend also on the large inter-patient variability observed in
HA or VMAT (large standard deviations), much less
marked for CK.
HA allowed also to better spare the healthy brain (de-
fined as the brain minus the targets) in the very low dose
region (V4Gy) while no differences were observed for
V12Gy and RPI. Volumes which receive 4 and 12 Gy
(V4Gy and V12Gy) are the smallest for HA technique. In
each plan, dose 4 and 12 Gy have the smallest volume
for HA technique, but only for V4Gy differences are sta-
tistically significant for the median dose. It is important
to remember that 4 (or 10) Gy given in one fraction
Fig. 6 Summary of the analysis of the data for the organs at risk
Fig. 7 Summary of the analysis of the data for the healthy brain. In the first panel the mean dose is reported while in the second and in the third panels
the V12Gy and the V4Gy data
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would result in different biological effect than given in
two or more fractions.
The multiparametric nature of the OAR sparing (and
target goverage) makes hard to identify a single reason
to justify the difference in sparing between lenses and
eyes compared to the healthy brain. Certainly, the tech-
nical implementation of HA inherently contributes to a
better sparing of the tissue surrounding the targets, and
this is mostly given by the healthy brain in the patients
we investigated; but this not necessarily at the expense,
as a trade-off, of reduced sparing capability of the other
structures. On the other hand, the quasi-blind planning
methodology adopted for the comparison, could play a
role in the different sparing of the eyes and the lenses.
In all cases and for all techniques, the dosimetric find-
ings were within planning aims which only required to
minimize the dose to the OARs without the imposition
of numerical fixed objectives. For example, the average
near to maximum dose to the lenses (Fig. 6) resulted
“low” for all techniques, below the normally clinically ac-
cepted threshold of 10Gy. Different efforts in the
optimization process might have better harmonized the
differences between the techniques. This might be con-
sidered as a limitation of the study design but it reflects
the clinical practice in the home institute.
With different fractionation schemes it might have been
possible to report either biologically equivalent doses (i.e.
corrected per fractionation) of to report relative doses.
Both approaches would lead to somehow similar conclu-
sions although with numerical differences. Nevertheless,
the calculation of biological equivalent doses in the stereo-
tactic frame would be affected by some additional uncer-
tainty due to the calculation parameters, while the relative
report would have partially masked the possibility to dir-
ectly correlate the results from different techniques vs
possible clinical implications. We opted to report the re-
sults in terms of the volume of healthy brain receiving ab-
solute levels (4 or 12Gy) of physical dose being this an
objective quantity, irrespectively from fractionation. Of
course, the clinical relevance of the findings should have
to be proven in a clinical experiment.
The analysis of the RPI metric indicated that the plans
made for the CK technique are closest to the planning ex-
pectations if all the structures are taken into account but
at the boundary of statistical significance (p = 0.05). If only
the targets and the healthy brain are considered, then all
the three techniques resulted basically equivalent. These
results support two arguments. Firstly, a tool like RPI
would require the availability of plans optimized with very
stringent criteria for all the included structures (and this
was not sufficient for some of the organs at risk as dis-
cussed above). Secondly, limiting to the two primary
structures (target and healthy brain), all three techniques
resulted very comparable in relative quality. It is also im-
portant to mention that, quality based metrics like the
RPI, are subject to some arbitrariety. In fact, if in the RPI
formula the weighting factor for the healthy brain would
be increased, giving more relevance to this structure, then
it would be possible to “over” express the relevance of one
particular structure and bias the global metric.
As a conclusive remark, it is important to stress that, as
in all planning comparisons, it is difficult to manage differ-
ent systems (and optimization engines) in a completely
coherent way. This would be necessary ideally in order to
guarantee that all the parameters are ta least maintained
except the ones which can be improved or which are fun-
damental for the study. As mentioned, differences in the
algorithms and in the interfaces, as well as in the planners
preferences, cannot be completely mitigated or eliminated.
The current study was designed in a way to possibly
minimize all these effects but some could still be present
as discussed but should not invalidate the global message
of substantial equivalence among the different approaches.
Conclusions
The recently released HA method for the SRS irradiation
of multiple metastases was investigated in comparison to
CK and VMAT techniques. From a dosimetric standpoint,
a b
Fig. 8 Summary of the analysis of the RPI. In the first panel when all the structures per each plan are included and in the second panel when only the
targets and the healthy brain are considered
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all techniques proved to be comparable from a clinical
viewpoint while the integrated and automated HA sug-
gested a remarkable improvement in the delivery time. A
comprehensive quality metrics for the plans, restricted to
the analysis of the healthy brain and the target volumes,
proved that HA can maximize the sparing of the brain
without compromising the target coverage. Further stud-
ies and clinical reports are required to confirm these early
observations.
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